What are the possible causes of hematuria and proteinuria in a patient with a urinalysis showing one plus protein, no leukocytes, no nitrates, and no ketones?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hematuria with Trace Proteinuria: Differential Diagnosis

The combination of hematuria with 1+ proteinuria (without leukocytes, nitrites, or ketones) most commonly suggests either glomerular disease, urologic malignancy, or benign causes like exercise or hypercalciuria, and requires systematic evaluation to distinguish between these possibilities. 1

Initial Diagnostic Approach

Confirm True Hematuria

  • Verify microscopic hematuria with ≥3 RBCs per high-power field on at least two of three properly collected specimens, as dipstick alone has limited specificity (65-99%) and can yield false positives 2, 3
  • Exclude benign transient causes: menstruation, vigorous exercise, sexual activity, viral illness, trauma, and recent urologic procedures by repeating urinalysis 48 hours after cessation 1, 2

Quantify Proteinuria

  • Obtain 24-hour urine collection or spot urine protein-to-creatinine ratio to determine if proteinuria is significant (>500 mg/24 hours suggests glomerular disease) 1, 2
  • 1+ protein on dipstick is typically <500 mg/24 hours, but quantification is essential 2

Determine Source: Glomerular vs. Non-Glomerular

Examine Urinary Sediment

  • Look for dysmorphic RBCs (>80% suggests glomerular origin) vs. normal-shaped RBCs (>80% suggests urologic source) 1, 2
  • Red cell casts are pathognomonic for glomerular bleeding, though relatively insensitive 1, 2
  • Phase contrast microscopy may be needed for accurate RBC morphology assessment 1

Assess Renal Function

  • Measure serum creatinine, BUN, and complete metabolic panel 2, 3
  • Elevated creatinine strongly suggests renal parenchymal disease 1, 2

Major Diagnostic Categories

Glomerular Causes (if dysmorphic RBCs, proteinuria >500 mg/24h, or elevated creatinine)

  • Post-infectious glomerulonephritis (occurs 7-21 days after streptococcal infection, low C3 levels) 4, 5
  • IgA nephropathy (Berger disease) - most common primary glomerulonephritis 1, 5
  • Thin basement membrane nephropathy (benign familial hematuria) - autosomal dominant, usually benign course 1
  • Alport syndrome (hereditary nephritis with hearing loss) 1, 3
  • Lupus nephritis or other vasculitis 5

Urologic Causes (if normal-shaped RBCs, minimal proteinuria, normal creatinine)

  • Malignancy risk increases with age >40 years, smoking history, occupational chemical exposure 1, 3
    • Bladder cancer (most common malignancy in hematuria cases) 3
    • Renal cell carcinoma 3
    • Transitional cell carcinoma 3
  • Urolithiasis (kidney/ureteric stones) - often presents with pain 3
  • Urinary tract infection - though your patient lacks leukocytes/nitrites, culture may still be warranted 3
  • Benign prostatic hyperplasia (in men) 3

Metabolic/Benign Causes

  • Hypercalciuria (common cause of microscopic hematuria, sometimes with mild proteinuria) 1, 3
  • Hyperuricosuria 1
  • Nutcracker syndrome (left renal vein compression) 3
  • Exercise-induced hematuria (transient) 3

Risk Stratification for Urologic Malignancy

High-risk features requiring immediate urologic evaluation: 1, 2

  • Age >40 years (men) or >60 years (women)
  • Smoking history >30 pack-years
  • History of gross hematuria
  • Occupational exposure to benzenes or aromatic amines
  • History of urologic disorder
  • Irritative voiding symptoms
  • History of pelvic irradiation

Recommended Evaluation Algorithm

If Glomerular Source Suspected

  • Refer to nephrology if: 1, 2
    • Proteinuria >1,000 mg/24 hours
    • Proteinuria >500 mg/24 hours that is persistent or increasing
    • Red cell casts present
    • Predominantly dysmorphic RBCs (>80%)
    • Elevated or rising serum creatinine
  • Consider complement levels (C3, C4), ANA, ANCA testing 3
  • Renal ultrasound to assess kidney size and echogenicity 1, 3
  • Renal biopsy may be needed for definitive diagnosis 1, 6

If Urologic Source Suspected or High-Risk Patient

  • Complete urologic evaluation includes: 1, 2
    • Multiphasic CT urography (preferred imaging for upper tract) 2, 3
    • Cystoscopy (mandatory for bladder evaluation) 2, 3
    • Urine cytology (especially in high-risk patients) 2, 3
  • Urine culture if infection suspected despite negative dipstick 3

If Low-Risk with Minimal Findings

  • Screen for hypercalciuria (urine calcium-to-creatinine ratio) 1, 3
  • Screen family members' urine for benign familial hematuria 1
  • Renal ultrasound may identify occult anatomic abnormalities, though yield is low 1

Follow-Up Protocol

If initial evaluation is negative but hematuria persists: 2, 3

  • Repeat urinalysis at 6,12,24, and 36 months
  • Monitor blood pressure at each visit
  • Consider nephrology referral if hematuria persists with development of hypertension, proteinuria, or evidence of glomerular bleeding

Critical Pitfalls to Avoid

  • Never attribute hematuria to anticoagulation or antiplatelet therapy alone - these medications may unmask underlying pathology but do not cause hematuria 2, 3
  • Gross hematuria requires urgent urologic referral even if self-limited, as it has 30-40% association with malignancy 3
  • The combination of hematuria and proteinuria significantly increases likelihood of serious renal disease and warrants more aggressive evaluation than isolated findings 7, 6
  • Absence of leukocytes/nitrites does not exclude infection - culture may still be indicated 3
  • 1+ proteinuria may seem minimal, but requires quantification to determine if it meets threshold for nephrology referral 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Urinalysis with Proteinuria and Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hematuria Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of Proteinuria and Hematuria in Ambulatory Setting.

Pediatric clinics of North America, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.